You are required to be logged in to access the full website
User Name: Password:
Click here if you have forgotten your username or password
  • Home
  • Latest News
  • Search
  • About M2 Pharma
  • Subscribe
Business & Finance
Generics
Therapy Areas
Policy & Regulation
Research & Development
People
Therapy Areas: Respiratory
Whitehawk Therapeutics presents ADC preclinical data at AACR 2026
Login
Username:

Password:


Related Headlines

Whitehawk Therapeutics presents ADC preclinical data at AACR 2026

European Commission approves Merck's ENFLONSIA for infant RSV prevention in Europe

Philips secures FDA clearance for Spectral CT Verida system

GSK strengthens pulmonary hypertension pipeline with USD950m acquisition of 35Pharma

hVIVO signs influenza human challenge trial agreement with Traws Pharma

GSK reports strong early-stage data for B7-H4 ADC in gynaecological cancers

FDA grants priority review to ifinatamab deruxtecan in small cell lung cancer

GSK secures China approval for Exdensur to treat nasal polyp condition

Dexcel Pharma's Nintedanib Capsules approved for US launch

Gilead to acquire Tubulis to expand ADC oncology capabilities

Sanofi reports positive phase 2 results for lunsekimig in asthma and CRSwNP

Akeso reports updated data on cadonilimab combination therapy in PD-(L)1 inhibitor-resistant advanced NSCLC data

Parnell launches first FDA-approved generic florfenicol and flunixin combination for bovine respiratory disease

Frontier Medicines licenses FMC-220 oncology programme to LG Chem in global deal

ALK secures EU approval for EURneffy 1 mg as needle-free adrenaline option for children

Home | Business & Finance | Generics | Therapy Areas | Policy & Regulation | Research & Development | People | Search | About M2 Pharma | Subscribe
Copyright © 2026